Depomed Announces Closing of Acquisition of U.S. Rights to Cebranopadol From Grunenthal
“We are pleased to add this first-in-class, late-stage molecule to our commercial portfolio as it marks a further transformation of
As previously announced on
The statements that are not historical facts contained in this release are forward-looking statements that involve risks and uncertainties including, but not limited to, those related to
Acuform® is a registered trademark of
OPANA® is a registered trademark of
Christopher KeenanVP, Investor Relations and Corporate Communications 510-744-8000 firstname.lastname@example.org
Minimum 15 minutes delayed.